Johnson & Johnson's COVID-19 Vaccine Proves Successful in South Africa
Voice of America
Johnson & Johnson's COVID-19 has had positive results in South Africa, the co-head of a trial, Glenda Gray, told reporters Friday.
A research study conducted from mid-February to May with upwards of 470,000 health workers showed positive results in those inoculated, and the country’s health regulator approved the single-shot J&J vaccine in Apri. It is being used in addition to Pfizer's. The study showed 91% to 96.2% protection against death, Gray said, and 67% efficacy against infection when the beta coronavirus dominated and 71% when the delta variant did. As of Thursday, more than 8.3 million people had been vaccinated in South Africa.More Related News
FILE - Activists participate in a demonstration against fossil fuels at the COP29 U.N. Climate Summit, in Baku, Azerbaijan, Nov. 16, 2024. FILE - Pipes are stacked up to be used for the Trans-Adriatic Pipeline project in Durres, Albania, April 18, 2016, to transport gas from the Shah Deniz II field in Azerbaijan, across Turkey, Greece, Albania and undersea into southern Italy.